TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference

Rhea-AI Summary

TELA Bio (NASDAQ: TELA), a commercial-stage medical technology company specializing in soft-tissue reconstruction solutions, has announced its participation in Piper Sandler's 36th Annual Healthcare Conference. The company's management team will deliver a presentation on December 3rd, 2024, at 12:00 pm ET. Investors and interested parties can access both the live presentation and archived webcast through the company's investor relations website at ir.telabio.com.

News Market Reaction – TELA

-0.34%

-0.34% Session move

In the trading session that priced this news, TELA declined 0.34%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MALVERN, Pa., Nov. 19, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in Piper Sandler’s 36^th Annual Healthcare Conference.

TELA’s management is scheduled to present at Piper Sandler’s 36^th Annual Healthcare Conference at 12:00 pm ET on December 3^rd, 2024. Interested parties can access the live and archived webcast at ir.telabio.com.

About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.

Investor Contact
Greg Chodaczek
347-620-7010
ir@telabio.com

FAQ

When is TELA Bio presenting at Piper Sandler's Healthcare Conference 2024?

TELA Bio is scheduled to present at Piper Sandler's 36th Annual Healthcare Conference on December 3rd, 2024, at 12:00 pm ET.

How can investors watch TELA Bio's presentation at the Piper Sandler Conference?

Investors can watch both the live presentation and archived webcast through TELA Bio's investor relations website at ir.telabio.com.

What is TELA Bio's main business focus?

TELA Bio is a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions.

Which stock exchange is TELA Bio listed on?

TELA Bio is listed on the NASDAQ stock exchange under the ticker symbol TELA.